Literature DB >> 1519843

Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans.

T R Rasmussen1, S K Kjaergaard, U Tarp, O F Pedersen.   

Abstract

Potential toxic effects of prolonged NO2 exposure below the current threshold limit value (TLV) were examined in 14 healthy, nonsmoking adults. The subjects were exposed to 2.3 ppm NO2 and to clean air for 5 h with a 1-wk interval between exposures. Physiologic and biochemical measurements were obtained during the exposures and until 24 h after. A 14% decrease in serum glutathione peroxidase activity (GSH-Px) was observed 24 h after the start of the NO2 exposure, while indications of a 22% decrease in alveolar permeability were found 11 h after the start. There were no indications of mucous membrane irritation or of decreased lung function during or after NO2 exposures. The results support the assumption that a delayed response is a feature of the human reaction to NO2 even below the current TLV of 3 ppm, and they stress the importance of an extended period of observation in future NO2 exposure studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519843     DOI: 10.1164/ajrccm/146.3.654

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  Inhaled nitric oxide and pulmonary vasoreactivity.

Authors:  M Aranda; R G Pearl
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

2.  [Inhaled nitric oxide for the treatment of ARDS].

Authors:  H Lohbrunner; M Deja; T Busch; C D Spies; R Rossaint; U Kaisers
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

Review 3.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

Review 4.  Nitric oxide and asthma.

Authors:  B Zoritch
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

Review 5.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

6.  Evaluation of electrochemical nitric oxide and nitrogen dioxide analyzers suitable for use during mechanical ventilation.

Authors:  E P Purtz; D Hess; R M Kacmarek
Journal:  J Clin Monit       Date:  1997-01

Review 7.  Nitric oxide for respiratory failure in infants born at or near term.

Authors:  Keith J Barrington; Neil Finer; Thomas Pennaforte; Gabriel Altit
Journal:  Cochrane Database Syst Rev       Date:  2017-01-05

Review 8.  Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

Authors:  Duncan J Macrae; David Field; Jean-Christophe Mercier; Jens Møller; Tom Stiris; Paolo Biban; Paul Cornick; Allan Goldman; Sylvia Göthberg; Lars E Gustafsson; Jürg Hammer; Per-Arne Lönnqvist; Manuel Sanchez-Luna; Gunnar Sedin; Nim Subhedar
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

9.  Inhaled nitric oxide in acute respiratory failure: dose-response curves.

Authors:  L Puybasset; J J Rouby; E Mourgeon; T E Stewart; P Cluzel; M Arthaud; P Poète; L Bodin; A M Korinek; P Viars
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

10.  Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations.

Authors:  M Moutafis; Z Hatahet; M H Castelain; M H Renaudin; A Monnot; M Fischler
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.